The notion that we can simultaneously demand expedited approvals while gutting the agency is misguided.

The National Security Commission on Emerging Biotechnology (NSCEB) announced on April 8, 2025, the availability of its final ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...